| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |